Selected research
Industry Growth & Trends
Global Parenteral Nutrition Solutions Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Parenteral Nutrition Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Parenteral Nutrition Solutions market include Teva Pharmaceutical Industries, Pfizer (Hospira), Fresenius, B. Braun, Baxter International Inc., PSI Ltd, Pisa, Patheon and Ozon Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Parenteral Nutrition Solutions market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Parenteral Nutrition Solutions market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parenteral Nutrition Solutions market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parenteral Nutrition Solutions.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Parenteral Nutrition Solutions market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Parenteral Nutrition Solutions Market by Company
Teva Pharmaceutical Industries
Pfizer (Hospira)
Fresenius
B. Braun
Baxter International Inc.
PSI Ltd
Pisa
Patheon
Ozon Pharmaceuticals
Ostuka Pharmaceutical
Kelun Pharma
Huaren
CR Double-Crane
Cook Pharmica
BML Parenteral Drugs
Beximco Pharma
BAG Healthcare
Aspen Holdings
Albert David
Parenteral Nutrition Solutions Segment by Type
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
Parenteral Nutrition Solutions Segment by Application
Basic Infusion
Nutritious Infusion
Therapeutic Infusion
Parenteral Nutrition Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Parenteral Nutrition Solutions companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
Applications
- Basic Infusion
- Nutritious Infusion
- Therapeutic Infusion
Companies covered
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Fresenius
- B. Braun
- Baxter International Inc.
- PSI Ltd
- Pisa
- Patheon
- Ozon Pharmaceuticals
- Ostuka Pharmaceutical
- Kelun Pharma
- Huaren
- CR Double-Crane
- Cook Pharmica
- BML Parenteral Drugs
- Beximco Pharma
- BAG Healthcare
- Aspen Holdings
- Albert David
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Parenteral Nutrition Solutions Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Parenteral Nutrition Solutions Market Size by Region (2021-2032)
- 1.4.1 Global Parenteral Nutrition Solutions Market Size by Region (2021-2026)
- 1.4.2 Global Parenteral Nutrition Solutions Market Size by Region (2027-2032)
- 1.5 Key Regions Parenteral Nutrition Solutions Market Size (2021-2032)
- 1.5.1 North America Parenteral Nutrition Solutions Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Parenteral Nutrition Solutions Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Parenteral Nutrition Solutions Market Size Growth Rate (2021-2032)
- 1.5.4 South America Parenteral Nutrition Solutions Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Parenteral Nutrition Solutions Market Size Growth Rate (2021-2032)
2 Parenteral Nutrition Solutions Market by Type
- 2.1 Type Introduction
- 2.1.1 Large Volume Parenteral (LVP)
- 2.1.2 Small Volume Parenteral (SVP)
- 2.2 Global Parenteral Nutrition Solutions Market Size by Type
- 2.2.1 Global Parenteral Nutrition Solutions Market Size Overview by Type (2021-2032)
- 2.2.2 Global Parenteral Nutrition Solutions Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Parenteral Nutrition Solutions Market Size Forecasted by Type (2027-2032)
- 2.3 Global Parenteral Nutrition Solutions Market Size by Regions
- 2.3.1 North America Parenteral Nutrition Solutions Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Parenteral Nutrition Solutions Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Parenteral Nutrition Solutions Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Parenteral Nutrition Solutions Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Parenteral Nutrition Solutions Market Size Breakdown by Type (2021-2026)
3 Parenteral Nutrition Solutions Market by Application
- 3.1 Type Introduction
- 3.1.1 Basic Infusion
- 3.1.2 Nutritious Infusion
- 3.1.3 Therapeutic Infusion
- 3.2 Global Parenteral Nutrition Solutions Market Size by Application
- 3.2.1 Global Parenteral Nutrition Solutions Market Size Overview by Application (2021-2032)
- 3.2.2 Global Parenteral Nutrition Solutions Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Parenteral Nutrition Solutions Market Size Forecasted by Application (2027-2032)
- 3.3 Global Parenteral Nutrition Solutions Market Size by Regions
- 3.3.1 North America Parenteral Nutrition Solutions Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Parenteral Nutrition Solutions Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Parenteral Nutrition Solutions Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Parenteral Nutrition Solutions Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Parenteral Nutrition Solutions Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Parenteral Nutrition Solutions Industry Trends
- 4.2 Parenteral Nutrition Solutions Industry Drivers
- 4.3 Parenteral Nutrition Solutions Industry Opportunities and Challenges
- 4.4 Parenteral Nutrition Solutions Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Parenteral Nutrition Solutions Revenue (2021-2026)
- 5.2 Global Parenteral Nutrition Solutions Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Parenteral Nutrition Solutions Key Company Headquarters & Area Served
- 5.4 Global Parenteral Nutrition Solutions Company, Product Type & Application
- 5.5 Global Parenteral Nutrition Solutions Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Parenteral Nutrition Solutions Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Parenteral Nutrition Solutions Players Market Share by Revenue in 2025
- 5.6.3 2025 Parenteral Nutrition Solutions Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Teva Pharmaceutical Industries
- 6.1.1 Teva Pharmaceutical Industries Company Information
- 6.1.2 Teva Pharmaceutical Industries Business Overview
- 6.1.3 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio
- 6.1.5 Teva Pharmaceutical Industries Recent Developments
- 6.2 Pfizer (Hospira)
- 6.2.1 Pfizer (Hospira) Company Information
- 6.2.2 Pfizer (Hospira) Business Overview
- 6.2.3 Pfizer (Hospira) Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio
- 6.2.5 Pfizer (Hospira) Recent Developments
- 6.3 Fresenius
- 6.3.1 Fresenius Company Information
- 6.3.2 Fresenius Business Overview
- 6.3.3 Fresenius Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fresenius Parenteral Nutrition Solutions Product Portfolio
- 6.3.5 Fresenius Recent Developments
- 6.4 B. Braun
- 6.4.1 B. Braun Company Information
- 6.4.2 B. Braun Business Overview
- 6.4.3 B. Braun Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 B. Braun Parenteral Nutrition Solutions Product Portfolio
- 6.4.5 B. Braun Recent Developments
- 6.5 Baxter International Inc.
- 6.5.1 Baxter International Inc. Company Information
- 6.5.2 Baxter International Inc. Business Overview
- 6.5.3 Baxter International Inc. Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio
- 6.5.5 Baxter International Inc. Recent Developments
- 6.6 PSI Ltd
- 6.6.1 PSI Ltd Company Information
- 6.6.2 PSI Ltd Business Overview
- 6.6.3 PSI Ltd Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 PSI Ltd Parenteral Nutrition Solutions Product Portfolio
- 6.6.5 PSI Ltd Recent Developments
- 6.7 Pisa
- 6.7.1 Pisa Company Information
- 6.7.2 Pisa Business Overview
- 6.7.3 Pisa Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pisa Parenteral Nutrition Solutions Product Portfolio
- 6.7.5 Pisa Recent Developments
- 6.8 Patheon
- 6.8.1 Patheon Company Information
- 6.8.2 Patheon Business Overview
- 6.8.3 Patheon Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Patheon Parenteral Nutrition Solutions Product Portfolio
- 6.8.5 Patheon Recent Developments
- 6.9 Ozon Pharmaceuticals
- 6.9.1 Ozon Pharmaceuticals Company Information
- 6.9.2 Ozon Pharmaceuticals Business Overview
- 6.9.3 Ozon Pharmaceuticals Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio
- 6.9.5 Ozon Pharmaceuticals Recent Developments
- 6.10 Ostuka Pharmaceutical
- 6.10.1 Ostuka Pharmaceutical Company Information
- 6.10.2 Ostuka Pharmaceutical Business Overview
- 6.10.3 Ostuka Pharmaceutical Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio
- 6.10.5 Ostuka Pharmaceutical Recent Developments
- 6.11 Kelun Pharma
- 6.11.1 Kelun Pharma Company Information
- 6.11.2 Kelun Pharma Business Overview
- 6.11.3 Kelun Pharma Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Kelun Pharma Parenteral Nutrition Solutions Product Portfolio
- 6.11.5 Kelun Pharma Recent Developments
- 6.12 Huaren
- 6.12.1 Huaren Company Information
- 6.12.2 Huaren Business Overview
- 6.12.3 Huaren Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Huaren Parenteral Nutrition Solutions Product Portfolio
- 6.12.5 Huaren Recent Developments
- 6.13 CR Double-Crane
- 6.13.1 CR Double-Crane Company Information
- 6.13.2 CR Double-Crane Business Overview
- 6.13.3 CR Double-Crane Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 CR Double-Crane Parenteral Nutrition Solutions Product Portfolio
- 6.13.5 CR Double-Crane Recent Developments
- 6.14 Cook Pharmica
- 6.14.1 Cook Pharmica Company Information
- 6.14.2 Cook Pharmica Business Overview
- 6.14.3 Cook Pharmica Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Cook Pharmica Parenteral Nutrition Solutions Product Portfolio
- 6.14.5 Cook Pharmica Recent Developments
- 6.15 BML Parenteral Drugs
- 6.15.1 BML Parenteral Drugs Company Information
- 6.15.2 BML Parenteral Drugs Business Overview
- 6.15.3 BML Parenteral Drugs Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio
- 6.15.5 BML Parenteral Drugs Recent Developments
- 6.16 Beximco Pharma
- 6.16.1 Beximco Pharma Company Information
- 6.16.2 Beximco Pharma Business Overview
- 6.16.3 Beximco Pharma Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Beximco Pharma Parenteral Nutrition Solutions Product Portfolio
- 6.16.5 Beximco Pharma Recent Developments
- 6.17 BAG Healthcare
- 6.17.1 BAG Healthcare Company Information
- 6.17.2 BAG Healthcare Business Overview
- 6.17.3 BAG Healthcare Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 BAG Healthcare Parenteral Nutrition Solutions Product Portfolio
- 6.17.5 BAG Healthcare Recent Developments
- 6.18 Aspen Holdings
- 6.18.1 Aspen Holdings Company Information
- 6.18.2 Aspen Holdings Business Overview
- 6.18.3 Aspen Holdings Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Aspen Holdings Parenteral Nutrition Solutions Product Portfolio
- 6.18.5 Aspen Holdings Recent Developments
- 6.19 Albert David
- 6.19.1 Albert David Company Information
- 6.19.2 Albert David Business Overview
- 6.19.3 Albert David Parenteral Nutrition Solutions Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Albert David Parenteral Nutrition Solutions Product Portfolio
- 6.19.5 Albert David Recent Developments
7 North America
- 7.1 North America Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 7.3 North America Parenteral Nutrition Solutions Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 8.3 Europe Parenteral Nutrition Solutions Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Parenteral Nutrition Solutions Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 10.3 South America Parenteral Nutrition Solutions Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Parenteral Nutrition Solutions Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Parenteral Nutrition Solutions Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst